This Phase III, open-label, randomized, parallel-group, active-controlled, multicenter study is conducted to assess the immunogenicity and safety of a single dose of MenACYW conjugate vaccine when administered alone and in combination with other pediatric vaccines in healthy toddlers in South Korea, the Russian Federation, and Mexico.